Pill to cure chicken pox infection soon in India

Indian generic pharmaceuticals company Aurobindo Pharma is set to launch the anti-viral drug valacyclovir to treat chicken pox infection in India, according to reports.

Valacyclovir pills, particularly used for the treatment of chicken pox will be available soon in 500 mg and 1 gram in strength respectively.

Aurobindo has already secured an approval for manufacturing valacyclovir hydrochloride tablets from the US Food and Drug Administration (USFDA).

Valacyclovir is an antiviral drug used for the treatment and prevention of the herpes virus.

It is a very popular drug and also goes by the name Valtrex. This pill is most commonly known to treat herpes but is also used for a variety of other uses.

Valacyclovir is an antiviral medication that helps the body fight the virus and prevents it from spreading. Valacyclovir was approved for the use in children suffering from chicken pox.

Chicken pox is a common childhood disease caused by the varicella-zoster virus (VZV). Also known as human herpes virus 3 (HHV-3), varicella-zoster virus is one of the eight herpesviruses known to affect humans. It is characterized by a fever followed by itchy raw pox or open sores.

The air borne disease virus causing chicken pox is a very contagious illness that is caused by the varicella zoster virus.

It begins with skin rashes usually on the body and head and not hands, they become itchy raw pockmarks with small open sores which usually heal without scarring.

Chicken pox is spread easily through direct contact with the secretions from the rash. Many people do not get chicken pox more than once in their lifetime.

Also know as herpes zoster (or just zoster), shingles is a viral disease that causes a painful skin rash to occur with blisters in a limited area on one side of the body, often in a stripe pattern.

The same virus that causes chicken pox, varicella zoster virus, causes shingles. Once a person gets over chicken pox, it is not eliminated from the body completely and can go on and develop into shingles, usually many years after the initial infection.

Aurobindo Pharma Limited, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients.

The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.

The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing antibiotics, anti-retrovirals, CVS, CNS, gastroenterologicals, and anti-allergics, supported by an outstanding R&D set-up. The Company is marketing these products globally, in over 125 countries.